Estradiol, the most potent form of estrogen, is produced by a surprisingly wide range of biological “manufacturers” and, since the mid-twentieth century, by pharmaceutical companies as well. Your ovaries are the best-known source, but the testes, the brain, fat tissue, bone, and even certain bacteria and invertebrate animals all produce or metabolize this hormone. On the industrial side, most prescription estradiol starts as a plant sterol extracted from soybeans or wild yams, then undergoes chemical conversion in a factory until it is structurally identical to the molecule your body makes. The full story of who makes estradiol stretches from cellular enzymes to global supply chains, with a few evolutionary surprises in between.
The Ovary and the Two-Cell System
In premenopausal women, the ovarian follicle is the body’s main estradiol factory. The process relies on a partnership between two distinct cell layers that surround each developing egg. Theca cells, in the outer shell of the follicle, take cholesterol and convert it through a series of steps into androgens, primarily androstenedione. Granulosa cells, which line the inside, then receive those androgens and use the enzyme aromatase to convert them into estrogens. Classic laboratory work separating human granulosa cells from thecal elements showed that theca cells convert precursors all the way to estradiol and androstenedione, while granulosa cells are especially active at converting pregnenolone to progesterone and estrone.1The Journal of Clinical Endocrinology & Metabolism. Steroid Biosynthesis by Human Ovarian Granulosa and Thecal Cells Together, the two cell types accomplish what neither could do efficiently alone. This division of labor is sometimes called the “two-cell, two-gonadotropin” model because each cell type responds to a different pituitary hormone: theca cells to luteinizing hormone, granulosa cells to follicle-stimulating hormone.
Estradiol production from the ovaries rises and falls dramatically across the menstrual cycle. It surges in the days before ovulation, drops briefly at ovulation, rises again during the luteal phase, and falls sharply if pregnancy does not occur. This cyclical pattern drives many of estradiol’s downstream effects on the uterine lining, cervical mucus, and bone turnover. When the ovaries stop producing follicles at menopause, circulating estradiol plummets, though the hormone does not vanish from the body entirely.
Estradiol Production in Men and at Extragonadal Sites
Men produce estradiol too, and it is far from a trivial footnote. Within the testes, several cell types express aromatase, including Leydig cells, Sertoli cells, and even germ cells in some species. These cells convert testosterone and other androgens into estradiol locally. Research has shown that aromatase gene expression and the resulting active enzyme in male germ cells provide an additional production site for estrogen, and that estrogen receptors are widely distributed across testicular cells, pointing to a real functional role in male reproduction.2Physiology. Testicular Estrogens and Male Reproduction In men, estradiol influences sperm maturation, bone density, and fat distribution. Male blood levels of estradiol are lower than in premenopausal women but higher than in postmenopausal women, making the male body an underappreciated source of this hormone.
Outside the gonads, aromatase is expressed in fat tissue, bone, the lining of blood vessels, and parts of the brain. After menopause, these peripheral tissues become the main sources of estrogen in women. Estradiol continues to be formed at those extragonadal sites, but the amounts are small enough that they do not raise blood levels the way the ovaries once did. Instead, the locally produced estradiol acts in a paracrine or intracrine fashion, meaning it influences nearby cells without entering the general circulation in meaningful quantities.3PubMed. Aromatization of androgens in women: current concepts and findings This distinction matters clinically: a postmenopausal woman may have very low serum estradiol yet still have biologically active estradiol in her breast tissue or bones.
Estradiol Made in the Brain
The brain is one of the more remarkable sites of estradiol synthesis. Neurons and astrocytes in multiple brain regions express aromatase and produce estradiol independently of the ovaries or testes. This brain-derived estradiol acts rapidly and locally to modulate synaptic function, memory, and neuroprotection. Rather than acting solely through the slow, classical pathway of binding a nuclear receptor and changing gene expression, brain-made estradiol can influence neurotransmission on a timescale of seconds to minutes.4PubMed Central. Brain-derived estrogen and neural function
This local production has been documented across many species, from songbirds to rodents to humans. In songbirds, brain estradiol synthesis fluctuates with the season and appears to regulate singing behavior. In rodents, it plays a role in spatial memory and hippocampal plasticity. These findings suggest that the brain’s ability to make its own estradiol is an ancient trait, not a quirk of one lineage. For the average reader, the practical implication is that brain estradiol levels do not simply mirror what is in the bloodstream. Someone whose ovaries or testes are producing very little estradiol can still have active estradiol signaling going on inside their skull.
Estradiol Across the Animal Kingdom
Estradiol is not exclusively a vertebrate molecule. Its presence has been confirmed in a surprisingly wide range of invertebrates, though its functional role varies. In rotifers, which are microscopic aquatic animals, researchers found an estrogen-like receptor whose binding site is not blocked and can bind human estradiol. When activated, that receptor regulates reproductive output in female rotifers, suggesting that estrogen signaling in reproduction stretches back hundreds of millions of years in evolutionary time.5PubMed Central. Conservation of estrogen receptor function in invertebrate reproduction
Sea urchins offer a different twist. Liquid chromatography-mass spectrometry confirmed the presence of estradiol in sea urchin tissues, but the hormone does not appear to play a central role in their reproductive processes the way it does in vertebrates or even in starfish.6PubMed. Unraveling estradiol metabolism and involvement in the reproductive cycle of non-vertebrate animals: The sea urchin model The molecule is there, but the job it does differs from one animal group to another. This patchwork of function suggests that estradiol, or at least the enzymatic machinery that produces it, was present in common ancestors of these groups, and that different lineages repurposed or downgraded it over evolutionary time.
How Scientists First Isolated Estrogen
The industrial production of estradiol is inseparable from the story of how the hormone was discovered. In 1923, Edgar Allen, a reproductive physiologist, was studying how follicular fluid from sow ovaries affected uterine weight, vaginal development, and sexual receptivity in laboratory animals. He teamed up with the biochemist Edward Doisy, who worked on purifying the active substance from those fluids. Progress was slow until Selmar Ascheim and Bernard Zondek, working in Germany, showed that the urine of pregnant women contained enormous amounts of estrogenic activity. With this richer biological source material in hand, Doisy crystallized estrone and presented the finding at an international physiology congress in 1929.7Endocrinology. History of Estrogen: Its Purification, Structure, Synthesis, Biologic Actions, and Clinical Implications Estradiol itself, which is more potent than estrone, was identified shortly afterward.
Those early isolation efforts established the basic molecular structure of the estrogens and paved the way for both synthetic chemistry and clinical use. Once chemists knew the exact arrangement of atoms, they could begin trying to build the molecule from scratch rather than extracting it from animal tissues. That shift from extraction to synthesis would eventually define the modern pharmaceutical industry’s approach.
From Plant Sterols to Pharmacy Shelves
Virtually all prescription estradiol today is manufactured by pharmaceutical companies that start from plant-derived sterols, most commonly diosgenin from wild yams or stigmasterol from soybeans. These plant molecules share a similar four-ring steroid backbone with human estradiol, which makes them excellent starting materials for chemical conversion. Through a series of reactions that modify side chains, add or remove functional groups, and adjust the stereochemistry, chemists transform these plant precursors into a molecule that is structurally indistinguishable from the estradiol your body produces.8PubMed. Bioidentical hormone therapy: a review of the evidence
This is the basis of what is often called “bioidentical” hormone therapy. The term can mislead people into thinking the hormone is somehow more natural than other pharmaceutical estrogens, but in practice it simply means the final product is molecularly identical to human estradiol, regardless of the fact that it was assembled in a chemical plant. Conjugated equine estrogens, by contrast, are a mixture of estrogens extracted from the urine of pregnant mares and contain compounds like equilin that do not naturally occur in the human body.
Total chemical synthesis of estradiol from non-steroid precursors is also possible, though it is primarily a research tool rather than a commercial manufacturing method. One published route, for example, achieved a six-step synthesis of an estradiol variant with a yield of about fifteen percent from readily accessible starting materials.9PubMed. A facile total synthesis of ent-17beta-estradiol and structurally related analogues These total-synthesis routes are invaluable for creating structural analogs used in laboratory research, where scientists need molecules that are slightly different from natural estradiol in order to probe how the hormone interacts with its receptors. For large-scale production, though, starting from a plant sterol that already has the correct ring structure is far more practical and cost-effective.
Plants That Mimic Estradiol
Plants do not produce estradiol itself, but many produce compounds called phytoestrogens that can interact with estrogen receptors in mammals. Phytoestrogens have structures very similar to human estradiol, which allows them to fit into estrogen receptor binding pockets, though typically with weaker affinity than the real hormone.10PubMed Central. Phytoestrogens and Their Health Effect The major classes include isoflavones (found in soy and red clover), lignans (found in flaxseed and whole grains), and coumestans (found in alfalfa and certain beans).
Research into how phytoestrogens bind estrogen receptors has focused on the structural features that determine selectivity. The shape, position of hydroxyl groups, and flexibility of the molecule all influence whether a phytoestrogen binds preferentially to one subtype of the estrogen receptor over another.11PubMed. Molecular aspects of phytoestrogen selective binding at estrogen receptors This selective binding is one reason phytoestrogens can have different effects in different tissues. In bone, a mild estrogenic effect might be beneficial; in breast tissue, the picture is more complicated and still debated.
It is worth clarifying a common misconception: eating soy or flaxseed does not deliver estradiol to your body. It delivers phytoestrogens, which are chemically distinct from estradiol even though they can weakly activate some of the same receptors. Fears that soy consumption will dramatically alter hormone levels in men, for example, are not supported by large reviews of the evidence at typical dietary intakes. Phytoestrogens are also completely different from the plant sterols (like diosgenin) used as chemical precursors in pharmaceutical manufacturing. Eating a yam will not give you bioidentical estradiol; the conversion requires industrial chemistry.
How Estradiol Talks to Cells
The classical pathway for estradiol signaling involves the hormone crossing a cell membrane, entering the nucleus, and binding to one of two nuclear estrogen receptors, known as ERα and ERβ. These receptors then bind to DNA and alter gene expression, a process that takes hours to produce visible effects. But that is not the whole story. In 2005, two independent research groups discovered that a G protein-coupled receptor called GPR30, now known as GPER, also binds estradiol and triggers rapid intracellular signaling cascades.12PubMed Central. Crosstalk between nuclear and G protein-coupled estrogen receptors
GPER sits on the cell surface (or on internal membranes) and, when activated by estradiol, can change cell behavior within seconds rather than hours. This fast-acting pathway helps explain some of estradiol’s effects that were hard to account for through gene expression alone, such as rapid changes in blood vessel tone or the quick modulation of neuronal firing in the brain. The existence of GPER also complicates drug development: a compound designed to block ERα and ERβ (like the cancer drug tamoxifen) may still activate GPER, potentially producing unexpected effects. This dual signaling system means that any discussion of “who makes estradiol” is incomplete without considering how many different cellular doorways the molecule can walk through once it is made.
Estradiol in the Water
Once estradiol is produced, whether by your body or by a pharmaceutical plant, it does not simply vanish. Both natural and synthetic estrogens enter waterways through sewage discharge, agricultural runoff, and pharmaceutical manufacturing effluent. A global inventory of estrogen levels in aquatic systems found that the cumulative risk to ecosystems is high at roughly two-thirds of the four hundred sampled sites worldwide. The review also revealed that almost no concentration data exist for open ocean areas, but estrogens have been detected in every type of water system examined, including open seas, suggesting the molecules persist longer in the environment than previously assumed.13PubMed. A Global Inventory of Natural and Synthetic Estrogens in Aquatic Systems
Even at very low concentrations, estrogens in water can feminize male fish, disrupting reproductive organs and reducing fertility in wild populations. This is not a theoretical concern; it has been documented in rivers downstream of major sewage treatment plants across multiple continents. The pharmaceutical industry has developed guidance for assessing and mitigating the environmental impact of active pharmaceutical ingredients in manufacturing wastewater, including selective use of treatment technologies.14Wiley Online Library. A risk-based approach to managing active pharmaceutical ingredients in manufacturing effluent But the larger volume of environmental estrogen comes from the billions of people whose bodies excrete natural estrogens daily, not from factory pipes.
Bacteria That Break Estradiol Down
Where there is pollution, evolution tends to find something that can eat it. Researchers studying wastewater treatment plants have identified specific bacterial species that can degrade estradiol and its metabolites. Metagenomic analysis of activated sludge, the microbial community used in sewage treatment, showed that Novosphingobium species are among the major estrogen degraders. One strain isolated from sludge was able to break down estrone, a close relative of estradiol.15PubMed Central. Estrogen Degraders and Estrogen Degradation Pathway Identified in an Activated Sludge
Other work in Upper Egypt isolated two bacterial strains from a sewage treatment plant, identified as Stenotrophomonas tumulicola and Serratia marcescens. When grown together, these bacteria degraded about 94% of estradiol in solution within 48 hours.16PubMed Central. Biodegradation of 17 β-estradiol by Serratia marcescens and Stenotrophomonas tumulicola co-culture isolated from a sewage treatment plant in Upper Egypt The efficiency of co-culture, where two species together outperform either one alone, is a recurring theme in bioremediation research. These findings suggest that optimizing the microbial communities in treatment plants could substantially reduce the amount of estradiol and related estrogens released into rivers and coastal waters.
The irony is worth noting: the same class of molecule that a human ovary spends considerable metabolic effort producing, and that a pharmaceutical company invests millions to synthesize and formulate, a pair of sewage bacteria can dismantle almost completely in two days. Estradiol’s journey, from cholesterol in your cells to a dissolved contaminant in a river to bacterial food in a treatment plant, captures the full arc of a molecule that is both essential for life and, in the wrong place, an ecological hazard.